Human Reproductive Hormones and Pharmacology

The menstrual cycle can be divided into phases based on hormonal changes that dictate physiological processes.

Hormonal Activity:
- Initially marked by an increase in Follicular Stimulating Hormone (FSH).
- An increase in estrogen secretion occurs in this phase from developing follicles.
Negative Feedback Mechanism:
- As estrogen levels rise significantly, they lead to a decrease in FSH production due to negative feedback on the pituitary gland.
Duration:
- Days 1-5: Menstruation occurs at the beginning of the cycle.
- Days 6-14: Development of ovarian follicles leading to increased estrogen levels.
Ovulation:
- Typically occurs around day 14, triggered by a significant rise in estrogen levels.
- This rise triggers a surge in Luteinizing Hormone (LH), leading to the release of the egg from the dominant ovarian follicle.

Development of Corpus Luteum:
- The ruptured follicle transforms into the corpus luteum, which secretes progesterone primarily along with some estrogen.
Physiological Effects:
- Role of Estrogen:
- Early in the luteal phase, estrogen is more prominent, contributing to the thickening of the endometrium (uterus lining) in preparation for potential implantation of an embryo.
- Role of Progesterone:
- In the second half of the luteal phase, progesterone prepares the endometrium for implantation by developing secretory endometrial cells and reducing estrogenic stimulation.
Hormonal Overview:
- Increased progesterone dominant in this phase, while estrogen supports the preparations for implantation. If implantation does not occur, the corpus luteum degrades, resulting in decreased levels of estrogen and progesterone, leading to menstruation.

Contraceptive Strategies:
- Many contraceptives increase progesterone levels to inhibit ovulation (prevent the release of eggs).
- Some contraceptives combine estrogen and progesterone to achieve hormonal balance and prevent undesirable bleeding.
PMS (Premenstrual Syndrome):
- Hormonal fluctuations throughout the menstrual cycle, particularly the swing from estrogen to progesterone, can lead to PMS.
- Symptoms include mood swings, irritability, anxiety, physical discomfort (such as breast tenderness, bloating, and headaches).
- First line treatments could include SSRIs (selective serotonin reuptake inhibitors) and oral contraceptives that regulate hormonal levels.

Definition:
- A condition where endometrial tissue grows outside the uterus, most often in the pelvic area.
Symptoms:
- Painful periods, inflammation, cysts, and lesions can occur, leading to painful symptoms and potential infertility.
Treatment:
- Can include NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), hormonal treatments where progesterone is particularly important to reduce endometrial proliferation.

Overview:
- Characterized by a long-term decrease in estrogen due to ovarian follicle depletion.
Diagnosis:
- Clinically diagnosed after 12 consecutive months with no menstrual periods.
Symptoms of Menopause:
- Hot flashes, night sweats, mood disorders, sleep difficulties, and urinary issues, along with a significant reduction in bone density (increased risk of osteoporosis).
Hormonal Treatments:
- Treatment primarily involves estrogen supplementation to alleviate symptoms and reduce osteoporosis risk.
- Must monitor for the risks associated with estrogen, such as clotting disorders and other complications.

Estrogens:
- Commonly used forms include transdermal patches, rings, or oral formulations.
- Side effects include breast tenderness, nausea, and risks associated with clotting (e.g., thromboembolic events).
- Contraindications include smoking, pregnancy, and pre-existing thromboembolic disorders.
Progestins:
- Used in contraception to prevent ovulation and to assist in treatment of endometrial hyperplasia.
- Can have side effects like weight gain, mood changes, and irregular bleeding.
- Similar contraindications as estrogen drugs.

Chemotherapy Overview:
- Utilized to target and destroy rapidly dividing cells, including cancer cells but also affecting healthy cells.
- Side effects can include myelosuppression (bone marrow suppression), leading to infections and other systemic complications.
Mechanisms and Types:
- Chemotherapy can be classified into cytotoxic agents that disrupt cellular replication, targeted therapies focused on specific cancer cell pathways, and immune therapies enhancing the body’s fight against cancer.
- Common adverse effects observe through chemotherapy include nausea, vomiting, alopecia, and fatigue.
Nursing Considerations for Cancer Care:
- Important to monitor for signs of infection, manage blood counts, and prepare patients for potential adverse reactions to treatment.
- Effective management incorporates hydration, drug potency, potential for drug interactions, and lifestyle adjustments to minimize infection risks during treatment cycles.

Antineoplastic Agents:
- Drugs like methotrexate are used to treat various cancers including autoimmune disorders by disrupting DNA synthesis.
Hormonal Therapies:
- Tamoxifen used for estrogen-positive breast cancers functions as a selective estrogen receptor modulator (SERM).
Supportive Care:
- Ensuring patients receive required monitoring, hydration, nutrition, and psychological support during treatment regimens is essential.
For testing and clinical practice, students should know key drugs like methotrexate and tamoxifen while understanding their mechanisms of action and potential side effects.
Emphasis should be placed on fostering patient education around the risks and benefits of each therapy.